Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 66Rectal Neoplasms 61Colorectal Neoplasms 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Neoplasm Metastasis 12Lymphoma 12Burkitt Lymphoma 11Leukemia 9Unspecified Adult Solid Tumor, Protocol Specific 7Lymphoma, Non-Hodgkin 6Leukemia, Biphenotypic, Acute 6Carcinoma, Hepatocellular 6Stomach Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Gallbladder Neoplasms 5Bile Duct Neoplasms 5Acquired Immunodeficiency Syndrome 5Neoplasms 4HIV Infections 4Osteosarcoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3Esophageal Neoplasms 3Sarcoma 2Ovarian Neoplasms 2Neoplasms, Unknown Primary 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2

Interventions

Melphalan 3sargramostim 1romidepsin 1montanide ISA 51 1keyhole-limpet hemocyanin 1detox adjuvant 1Waiting Lists 1Thalidomide 1Radiosurgery 1Radiation 1Leucovorin 1Ketoconazole 1Interleukin-2 1Floxuridine 1FANG vaccine 1Docetaxel 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Genetic Diseases, Inborn × Leucovorin × Clear all
NCT00019760 2023-10-31

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡